TETRAHYDROZOLINE HYDROCHLORIDE

TETRAHYDROZOLINE HYDROCHLORIDE was reported 294 times

TETRAHYDROZOLINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STEROID DEPENDENCE 82 0.0934
1 CATARRH 83 0.0918
2 BURNS SECOND DEGREE 84 0.0478
3 ORBITAL DECOMPRESSION 1 0.0435
4 BRONCHIAL ANASTOMOSIS COMPLICATION 1 0.0417
5 URINE VISCOSITY INCREASED 2 0.0392
6 ALCOHOL POISONING 70 0.0261
7 HYPOPNOEA 84 0.0242
8 PHARYNGEAL EXUDATE 1 0.0233
9 RESPIRATORY RATE 1 0.0208
10 VASCULAR ACCESS MALFUNCTION 1 0.0185
11 FEMORAL NERVE INJURY 1 0.0139
12 STIFF LEG SYNDROME 1 0.0130
13 BRONCHIECTASIS 86 0.0128
14 PAROSMIA 83 0.0110
15 GINGIVAL PAIN 85 0.0107
16 RHINITIS 85 0.0105
17 NASAL VESTIBULITIS 1 0.0100
18 CARDIAC MURMUR 84 0.0097
19 EAR DRYNESS 1 0.0095
20 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
21 PNEUMOCOCCAL BACTERAEMIA 1 0.0079
22 UNWANTED PREGNANCY 1 0.0073
23 POST CHOLECYSTECTOMY SYNDROME 2 0.0071
24 CYSTIC LUNG DISEASE 1 0.0070
25 VITAMIN A DECREASED 1 0.0065
26 CREATININE URINE DECREASED 1 0.0063
27 BLADDER CYST 1 0.0062
28 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 4 0.0060
29 MEAN PLATELET VOLUME DECREASED 5 0.0060
30 ABDOMINAL LYMPHADENOPATHY 5 0.0058
31 IMPAIRED QUALITY OF LIFE 74 0.0051
32 DEAFNESS PERMANENT 1 0.0051
33 TRANSIENT TACHYPNOEA OF THE NEWBORN 2 0.0051
34 GRANULOCYTE COUNT INCREASED 2 0.0049
35 TUBULOINTERSTITIAL NEPHRITIS 81 0.0043
36 C-REACTIVE PROTEIN 4 0.0043
37 POST PROCEDURAL FEVER 1 0.0041
38 ASPARTATE AMINOTRANSFERASE 1 0.0041
39 MONOCYTE COUNT DECREASED 5 0.0041
40 IMPAIRED WORK ABILITY 82 0.0038
41 BLOOD IMMUNOGLOBULIN A INCREASED 2 0.0037
42 ENDOCRINE OPHTHALMOPATHY 3 0.0035
43 FREQUENT BOWEL MOVEMENTS 89 0.0033
44 IMPAIRED FASTING GLUCOSE 1 0.0033
45 WOUND INFECTION PSEUDOMONAS 1 0.0032
46 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
47 ECTROPION 1 0.0030
48 SPINAL NERVE STIMULATOR IMPLANTATION 1 0.0029
49 SWOLLEN TONGUE 83 0.0027
50 NASAL TURBINATE HYPERTROPHY 1 0.0027
51 VITAMIN B12 INCREASED 2 0.0025
52 PLACENTAL INSUFFICIENCY 2 0.0025
53 SYSTEMIC LUPUS ERYTHEMATOSUS 88 0.0025
54 NIGHTMARE 85 0.0025
55 GLOMERULAR FILTRATION RATE INCREASED 2 0.0024
56 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
57 ELECTRIC SHOCK 2 0.0023
58 ACCIDENTAL OVERDOSE 85 0.0023
59 SEXUAL ABUSE 1 0.0023
60 HEPATIC ENZYME DECREASED 1 0.0022
61 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
62 RECTAL HAEMORRHAGE 88 0.0020
63 DACTYLITIS 2 0.0020
64 DEEP VEIN THROMBOSIS POSTOPERATIVE 4 0.0020
65 CORNEAL SCAR 1 0.0020
66 POLYHYDRAMNIOS 2 0.0020
67 KELOID SCAR 1 0.0019
68 TINNITUS 89 0.0019
69 COLITIS ULCERATIVE 86 0.0019
70 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 90 0.0019
71 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
72 BRONCHOSTENOSIS 1 0.0018
73 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
74 RHEUMATOID FACTOR INCREASED 2 0.0018
75 COLLAGEN DISORDER 1 0.0017
76 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
77 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
78 ECZEMA 84 0.0016
79 HAEMATOCHEZIA 86 0.0016
80 MEDICATION ERROR 86 0.0015
81 POST PROCEDURAL SEPSIS 1 0.0015
82 PRECANCEROUS CONDITION 1 0.0015
83 VERTIGO 89 0.0015
84 DISCHARGE 2 0.0014
85 URINE LEUKOCYTE ESTERASE POSITIVE 1 0.0014
86 ATRIAL TACHYCARDIA 3 0.0014
87 DEEP VEIN THROMBOSIS 87 0.0013
88 BASOPHIL COUNT INCREASED 1 0.0013
89 ACCIDENTAL DRUG INTAKE BY CHILD 2 0.0013
90 PRODUCT CONFUSION 1 0.0013
91 SWOLLEN JOINT COUNT INCREASED 4 0.0013
92 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
93 ARTHROPOD STING 2 0.0012
94 DYSGEUSIA 86 0.0012
95 LIGAMENT DISORDER 1 0.0011
96 CERUMEN IMPACTION 1 0.0011
97 INTERVERTEBRAL DISCITIS 2 0.0011
98 ARTHRITIS 83 0.0011
99 POISONING DELIBERATE 10 0.0011
100 INTENTIONAL PRODUCT USE ISSUE 90 0.0010
101 JOINT NOISE 2 0.0010
102 MUCOSAL DISORDER 1 0.0010
103 MIGRAINE 88 0.0009
104 RHEUMATIC FEVER 4 0.0009
105 FEAR OF DEATH 2 0.0009
106 PULMONARY EMBOLISM 83 0.0009
107 RECTAL ULCER 1 0.0009
108 MONOCYTE COUNT INCREASED 3 0.0008
109 PHARYNGEAL INFLAMMATION 1 0.0008
110 OTITIS EXTERNA 1 0.0008
111 ADVERSE DRUG REACTION 72 0.0008
112 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
113 BRONCHIAL SECRETION RETENTION 1 0.0008
114 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
115 DACRYOSTENOSIS ACQUIRED 1 0.0008
116 PERSONALITY DISORDER 2 0.0008
117 CARBON DIOXIDE INCREASED 1 0.0007
118 SKIN DEPIGMENTATION 1 0.0007
119 DEMYELINATION 3 0.0007
120 FAECALOMA 4 0.0007
121 RHINALGIA 2 0.0007
122 PALPITATIONS 85 0.0007
123 RHEUMATOID FACTOR POSITIVE 4 0.0007
124 UTERINE LEIOMYOMA 5 0.0007
125 NEUTROPHIL COUNT INCREASED 7 0.0007
126 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
127 LOCALISED OEDEMA 3 0.0006
128 C-REACTIVE PROTEIN ABNORMAL 4 0.0006
129 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
130 SHOULDER FRACTURE 1 0.0006
131 DEAFNESS NEUROSENSORY 2 0.0006
132 PAPILLOMA VIRAL INFECTION 1 0.0006
133 ACUTE SINUSITIS 1 0.0006
134 OTORRHOEA 1 0.0006
135 PSEUDOMONAL SEPSIS 1 0.0006
136 ABDOMINAL DISCOMFORT 94 0.0006
137 CONFUSIONAL STATE 90 0.0006
138 DEVICE ALARM ISSUE 1 0.0006
139 DUODENAL ULCER PERFORATION 4 0.0005
140 TUNNEL VISION 1 0.0005
141 THROAT CLEARING 2 0.0005
142 NASAL OBSTRUCTION 1 0.0005
143 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
144 RETINAL OEDEMA 1 0.0005
145 REHABILITATION THERAPY 2 0.0005
146 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 93 0.0005
147 EARLY SATIETY 1 0.0005
148 NASAL SEPTUM DEVIATION 1 0.0005
149 VITAMIN B12 DEFICIENCY 2 0.0005
150 COVID-19 86 0.0005
151 CEREBROVASCULAR ACCIDENT 82 0.0005
152 MUSCLE INJURY 4 0.0005
153 SKIN INDURATION 1 0.0005
154 ABNORMAL SENSATION IN EYE 2 0.0005
155 HORDEOLUM 2 0.0005
156 PLATELET COUNT INCREASED 6 0.0005
157 LIMB MASS 1 0.0005
158 CLOSTRIDIUM TEST POSITIVE 1 0.0005
159 LIP DRY 4 0.0004
160 SOMNOLENCE 88 0.0004
161 BREAKTHROUGH PAIN 1 0.0004
162 SUSPECTED SUICIDE 2 0.0004
163 SEASONAL ALLERGY 6 0.0004
164 OXYGEN CONSUMPTION INCREASED 1 0.0004
165 LACUNAR INFARCTION 1 0.0004
166 PULSE ABNORMAL 1 0.0004
167 PRODUCT PACKAGING CONFUSION 1 0.0004
168 AUTOIMMUNE DISORDER 4 0.0004
169 DEVICE INFUSION ISSUE 1 0.0004
170 CATHETER SITE HAEMORRHAGE 1 0.0004
171 HYPERPARATHYROIDISM SECONDARY 1 0.0004
172 VASODILATATION 1 0.0004
173 HELICOBACTER INFECTION 4 0.0004
174 MENOPAUSE 1 0.0004
175 CATHETER SITE PAIN 1 0.0004
176 DEPRESSION 87 0.0004
177 FOLLICULITIS 4 0.0004
178 HAND DEFORMITY 5 0.0004
179 PROTEIN TOTAL INCREASED 1 0.0004
180 WHITE BLOOD CELL DISORDER 1 0.0004
181 BLOOD SODIUM INCREASED 1 0.0004
182 ULCERATIVE KERATITIS 1 0.0004
183 TRICHORRHEXIS 1 0.0004
184 DIABETIC COMA 1 0.0004
185 EYE INFECTION 4 0.0004
186 CHOLECYSTITIS ACUTE 2 0.0004
187 OXYGEN SATURATION ABNORMAL 1 0.0004
188 OESOPHAGEAL STENOSIS 1 0.0004
189 PRODUCT USE IN UNAPPROVED INDICATION 86 0.0003
190 BLOOD URIC ACID INCREASED 2 0.0003
191 EYELID MARGIN CRUSTING 1 0.0003
192 VOMITING PROJECTILE 1 0.0003
193 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
194 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
195 NECK INJURY 1 0.0003
196 WEIGHT DECREASED 95 0.0003
197 LYMPHOCYTE COUNT DECREASED 6 0.0003
198 CRANIOCEREBRAL INJURY 1 0.0003
199 FOETAL GROWTH RESTRICTION 2 0.0003
200 IRRITABLE BOWEL SYNDROME 7 0.0003
201 DYSAESTHESIA 1 0.0003
202 PEMPHIGUS 4 0.0003
203 BLOOD CREATININE DECREASED 1 0.0003
204 SWELLING OF EYELID 2 0.0003
205 PRODUCT USE COMPLAINT 5 0.0003
206 RED BLOOD CELL COUNT DECREASED 9 0.0003
207 FOREIGN BODY SENSATION IN EYES 2 0.0003
208 EYE IRRITATION 18 0.0003
209 SKIN EROSION 1 0.0003
210 PRESCRIBED OVERDOSE 6 0.0003
211 PAIN IN EXTREMITY 91 0.0003
212 FACET JOINT SYNDROME 1 0.0003
213 CONDITION AGGRAVATED 93 0.0003
214 HAEMATOCRIT DECREASED 6 0.0003
215 EYE HAEMORRHAGE 4 0.0003
216 POST-TRAUMATIC STRESS DISORDER 2 0.0003
217 LYMPHOEDEMA 2 0.0003
218 EYE DISCHARGE 3 0.0003
219 HYPERREFLEXIA 1 0.0003
220 CAROTID ARTERY STENOSIS 1 0.0003
221 LUNG TRANSPLANT 1 0.0003
222 OCULAR HYPERAEMIA 13 0.0003
223 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
224 CONJUNCTIVITIS 5 0.0003
225 TENDON INJURY 1 0.0003
226 CHRONIC SINUSITIS 1 0.0003
227 PARANASAL SINUS DISCOMFORT 1 0.0003
228 LIPASE INCREASED 2 0.0003
229 PYREXIA 90 0.0003
230 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
231 MUSCLE RUPTURE 1 0.0003
232 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
233 SCIATICA 4 0.0003
234 CEREBRAL ATROPHY 1 0.0003
235 AZOTAEMIA 1 0.0003
236 MIOSIS 2 0.0002
237 PERIPHERAL VENOUS DISEASE 1 0.0002
238 ABNORMAL FAECES 2 0.0002
239 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
240 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
241 DRY EYE 12 0.0002
242 PERICARDITIS 4 0.0002
243 UTERINE HAEMORRHAGE 1 0.0002
244 PRODUCT CONTAINER ISSUE 2 0.0002
245 OCULAR ICTERUS 1 0.0002
246 LIGAMENT RUPTURE 1 0.0002
247 PHYSICAL DISABILITY 1 0.0002
248 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
249 RHINITIS ALLERGIC 1 0.0002
250 SYNOVITIS 4 0.0002
251 VASCULAR DEVICE INFECTION 1 0.0002
252 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
253 ABDOMINAL HERNIA 1 0.0002
254 RASH 95 0.0002
255 SYNOVIAL CYST 1 0.0002
256 RENAL FUNCTION TEST ABNORMAL 1 0.0002
257 BLOOD CHOLESTEROL INCREASED 10 0.0002
258 UMBILICAL HERNIA 1 0.0002
259 SKIN ABRASION 1 0.0002
260 SPINAL DISORDER 2 0.0002
261 CARDIOGENIC SHOCK 3 0.0002
262 EYE PRURITUS 7 0.0002
263 LOWER LIMB FRACTURE 4 0.0002
264 VITAMIN D DEFICIENCY 2 0.0002
265 FLUID INTAKE REDUCED 1 0.0002
266 LACRIMATION INCREASED 6 0.0002
267 HYPOTHERMIA 2 0.0002
268 PATHOLOGICAL FRACTURE 1 0.0002
269 DYSLIPIDAEMIA 1 0.0002
270 DRY THROAT 2 0.0002
271 WEIGHT LOSS POOR 1 0.0002
272 CEREBRAL ISCHAEMIA 1 0.0002
273 TEMPERATURE INTOLERANCE 2 0.0002
274 C-REACTIVE PROTEIN INCREASED 7 0.0002
275 APLASTIC ANAEMIA 1 0.0002
276 KNEE ARTHROPLASTY 4 0.0002
277 POLYARTHRITIS 1 0.0002
278 FULL BLOOD COUNT ABNORMAL 2 0.0002
279 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
280 PRODUCT RESIDUE PRESENT 1 0.0002
281 DECREASED ACTIVITY 2 0.0002
282 HIP SURGERY 1 0.0002
283 ERYTHEMA OF EYELID 1 0.0002
284 SKIN LACERATION 2 0.0002
285 ASPIRATION 2 0.0002
286 ASTHENOPIA 1 0.0002
287 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
288 GLOSSODYNIA 4 0.0002
289 SNEEZING 4 0.0002
290 TYPE 2 DIABETES MELLITUS 6 0.0002
291 OCULAR DISCOMFORT 2 0.0002
292 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
293 CARDIAC VALVE DISEASE 1 0.0002
294 SKIN ATROPHY 1 0.0002
295 RALES 1 0.0002
296 PRODUCT LABEL CONFUSION 1 0.0002
297 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
298 HEADACHE 106 0.0002
299 ODYNOPHAGIA 1 0.0002
300 BLOOD PRESSURE FLUCTUATION 4 0.0002
301 PELVIC PAIN 3 0.0002
302 ADRENAL INSUFFICIENCY 2 0.0002
303 FIBROMYALGIA 4 0.0002
304 LIVER INJURY 4 0.0002
305 MENISCUS INJURY 1 0.0002
306 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
307 PIGMENTATION DISORDER 1 0.0002
308 SCOLIOSIS 1 0.0002
309 PAIN 99 0.0002
310 CYST 2 0.0002
311 OLIGURIA 1 0.0002
312 SECRETION DISCHARGE 2 0.0002
313 EYE PAIN 9 0.0002
314 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
315 NIGHT SWEATS 5 0.0002
316 INCOHERENT 1 0.0002
317 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
318 TENDON DISORDER 1 0.0002
319 NODULE 2 0.0002
320 POLYP 1 0.0002
321 PRODUCT PREPARATION ISSUE 1 0.0002
322 IMPAIRED HEALING 5 0.0002
323 IMMUNE SYSTEM DISORDER 2 0.0002
324 BLOOD PRESSURE ABNORMAL 3 0.0002
325 CARDIAC FAILURE ACUTE 1 0.0001
326 PREGNANCY 3 0.0001
327 GAIT INABILITY 5 0.0001
328 PRODUCT LABEL ISSUE 1 0.0001
329 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
330 ONYCHOCLASIS 1 0.0001
331 LARGE INTESTINE POLYP 1 0.0001
332 COORDINATION ABNORMAL 2 0.0001
333 WOUND 4 0.0001
334 BLOOD TEST ABNORMAL 2 0.0001
335 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
336 FATIGUE 108 0.0001
337 SENSITIVE SKIN 1 0.0001
338 THERAPY NON-RESPONDER 6 0.0001
339 HYPOAESTHESIA ORAL 2 0.0001
340 HIP ARTHROPLASTY 2 0.0001
341 CONCUSSION 1 0.0001
342 APNOEA 1 0.0001
343 MULTIPLE ALLERGIES 1 0.0001
344 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
345 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
346 DRUG SCREEN POSITIVE 1 0.0001
347 ULCER 2 0.0001
348 BLOOD DISORDER 1 0.0001
349 UTERINE CANCER 1 0.0001
350 POST PROCEDURAL INFECTION 1 0.0001
351 EYE DISORDER 4 0.0001
352 BLOOD UREA INCREASED 2 0.0001
353 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
354 FLUID RETENTION 6 0.0001
355 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
356 VITAMIN D DECREASED 1 0.0001
357 ANURIA 1 0.0001
358 BLOOD MAGNESIUM DECREASED 1 0.0001
359 ORTHOSTATIC HYPOTENSION 2 0.0001
360 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
361 URINE OUTPUT DECREASED 1 0.0001
362 BRADYCARDIA 6 0.0001
363 FACIAL PAIN 1 0.0001
364 OFF LABEL USE 98 0.0001
365 DRY MOUTH 9 0.0001
366 ARTHROPATHY 6 0.0001
367 EYE SWELLING 4 0.0001
368 SQUAMOUS CELL CARCINOMA 1 0.0001
369 PRODUCT PACKAGING ISSUE 1 0.0001
370 EYE INFLAMMATION 1 0.0001
371 SINUS BRADYCARDIA 1 0.0001
372 LUNG DISORDER 5 0.0001
373 VITREOUS FLOATERS 1 0.0001
374 URINARY INCONTINENCE 3 0.0001
375 UPPER LIMB FRACTURE 2 0.0001
376 HYPOTONIA 1 0.0001
377 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
378 TASTE DISORDER 2 0.0001
379 PSORIATIC ARTHROPATHY 4 0.0001
380 EYELID PTOSIS 1 0.0001
381 DISCOMFORT 6 0.0001
382 MOTOR DYSFUNCTION 1 0.0001
383 EAR DISCOMFORT 1 0.0001
384 RIB FRACTURE 2 0.0001
385 POOR VENOUS ACCESS 1 0.0001
386 TENDERNESS 1 0.0001
387 PETECHIAE 1 0.0001
388 ROAD TRAFFIC ACCIDENT 4 0.0001
389 TRANSFUSION 1 0.0001
390 DYSPHAGIA 9 0.0001
391 OSTEOARTHRITIS 4 0.0001
392 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
393 POOR QUALITY SLEEP 2 0.0001
394 SKIN CANCER 2 0.0001
395 INTENTIONAL PRODUCT MISUSE 8 0.0001
396 TOOTH FRACTURE 1 0.0001
397 INFUSION RELATED REACTION 6 0.0001
398 DENTAL CARIES 1 0.0001
399 LIVER DISORDER 4 0.0001
400 NERVE INJURY 1 0.0001
401 HYPERTENSIVE CRISIS 1 0.0001
402 MALNUTRITION 1 0.0001
403 GASTROINTESTINAL DISORDER 8 0.0001
404 SKIN INFECTION 1 0.0001
405 IMPAIRED DRIVING ABILITY 1 0.0001
406 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
407 MYOCARDIAL ISCHAEMIA 1 0.0001
408 SCAB 1 0.0001
409 CAESAREAN SECTION 1 0.0001
410 SPINAL PAIN 1 0.0001
411 ACCIDENT 1 0.0001
412 HYPERLIPIDAEMIA 1 0.0001
413 MOBILITY DECREASED 6 0.0001
414 MENTAL IMPAIRMENT 2 0.0001
415 STOMATITIS 5 0.0001
416 BURSITIS 1 0.0001
417 ILL-DEFINED DISORDER 5 0.0001
418 PRESYNCOPE 2 0.0001
419 NEURALGIA 2 0.0001
420 RESPIRATORY DEPRESSION 1 0.0001
421 ENCEPHALOPATHY 2 0.0001
422 HYPERSENSITIVITY 15 0.0001
423 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
424 LEUKOPENIA 4 0.0001
425 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
426 PERIPHERAL SWELLING 12 0.0001
427 RHINORRHOEA 5 0.0001
428 DIPLOPIA 2 0.0001
429 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
430 BEDRIDDEN 1 0.0001
431 ORAL CANDIDIASIS 1 0.0001
432 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
433 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
434 EAR INFECTION 2 0.0001
435 JOINT RANGE OF MOTION DECREASED 1 0.0001
436 DRUG INEFFECTIVE 98 0.0001
437 OEDEMA 4 0.0001
438 HEPATIC ENZYME INCREASED 5 0.0001
439 CONTUSION 7 0.0001
440 MENTAL STATUS CHANGES 2 0.0001
441 ORAL DISCOMFORT 1 0.0001
442 POLLAKIURIA 3 0.0001
443 FEELING COLD 2 0.0001
444 HAEMOPTYSIS 2 0.0001
445 BLISTER 4 0.0001
446 INJURY 5 0.0001
447 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
448 FLATULENCE 4 0.0001
449 DIALYSIS 1 0.0001
450 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
451 PARALYSIS 1 0.0001
452 BALANCE DISORDER 6 0.0001
453 DYSSTASIA 2 0.0001
454 MUSCULOSKELETAL STIFFNESS 6 0.0001
455 NASAL CONGESTION 4 0.0001
456 WHEEZING 4 0.0001
457 PULMONARY MASS 1 0.0001
458 IMMUNODEFICIENCY 1 0.0001
459 EPISTAXIS 5 0.0001
460 JOINT SWELLING 8 0.0001
461 ECONOMIC PROBLEM 1 0.0001
462 VISION BLURRED 9 0.0001
463 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
464 THYROID DISORDER 1 0.0001
465 LYMPHOMA 1 0.0001
466 MUSCULOSKELETAL CHEST PAIN 1 0.0001
467 RENAL DISORDER 3 0.0001
468 BRAIN FOG 1 0.0001
469 HEAD INJURY 2 0.0001
470 ABDOMINAL PAIN UPPER 13 0.0001
471 RESPIRATORY TRACT CONGESTION 1 0.0001
472 OBESITY 1 0.0001
473 MOVEMENT DISORDER 2 0.0001
474 RHEUMATOID ARTHRITIS 7 0.0001
475 HEART RATE INCREASED 6 0.0001
476 NASOPHARYNGITIS 11 0.0001
477 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
478 TOXICITY TO VARIOUS AGENTS 10 0.0001
479 HEMIPARESIS 1 0.0001
480 SINUSITIS 6 0.0001
481 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
482 MUSCULOSKELETAL DISCOMFORT 1 0.0001
483 ABDOMINAL DISTENSION 6 0.0001
484 HEART RATE DECREASED 2 0.0001
485 VISUAL IMPAIRMENT 7 0.0001
486 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
487 THIRST 1 0.0001
488 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
489 RESTLESS LEGS SYNDROME 1 0.0001
490 HYPERGLYCAEMIA 2 0.0001
491 END STAGE RENAL DISEASE 1 0.0001
492 LOSS OF CONSCIOUSNESS 7 0.0001
493 ANAPHYLACTIC REACTION 3 0.0001
494 BLOOD GLUCOSE ABNORMAL 1 0.0001
495 WEIGHT INCREASED 12 0.0001
496 OXYGEN SATURATION DECREASED 3 0.0001
497 PHOTOPHOBIA 1 0.0001
498 DYSPNOEA EXERTIONAL 2 0.0001
499 ASTHMA 6 0.0001
500 NEUROPATHY PERIPHERAL 5 0.0001
501 MUSCULOSKELETAL DISORDER 1 0.0001
502 FEELING JITTERY 1 0.0001
503 LETHARGY 3 0.0001
504 ACUTE RESPIRATORY FAILURE 1 0.0001
505 GLAUCOMA 1 0.0001
506 EAR PAIN 1 0.0001
507 DYSPHONIA 3 0.0001
508 BONE PAIN 3 0.0001
509 SKIN FISSURES 1 0.0001
510 DYSPEPSIA 5 0.0001
511 DISABILITY 1 0.0001
512 SINUS DISORDER 1 0.0001
513 CONSTIPATION 11 0.0001
514 HYPOTENSION 10 0.0000
515 PRODUCT PHYSICAL ISSUE 1 0.0000
516 PRODUCT ADMINISTRATION ERROR 1 0.0000
517 BLINDNESS 2 0.0000
518 OSTEOPOROSIS 2 0.0000
519 INJECTION SITE WARMTH 1 0.0000
520 TREATMENT FAILURE 4 0.0000
521 ARTHRALGIA 20 0.0000
522 PULMONARY HYPERTENSION 1 0.0000
523 DECREASED APPETITE 11 0.0000
524 EATING DISORDER 1 0.0000
525 JOINT INJURY 1 0.0000
526 PRODUCT PRESCRIBING ISSUE 1 0.0000
527 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
528 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
529 TOOTH DISORDER 1 0.0000
530 INJECTION SITE PRURITUS 3 0.0000
531 THROAT IRRITATION 2 0.0000
532 CHROMATURIA 1 0.0000
533 MUSCULAR WEAKNESS 5 0.0000
534 MUSCLE SPASMS 8 0.0000
535 SKIN DISCOLOURATION 2 0.0000
536 MUSCLE TWITCHING 1 0.0000
537 COGNITIVE DISORDER 2 0.0000
538 SWELLING 4 0.0000
539 HYPERTENSION 9 0.0000
540 MULTIPLE SCLEROSIS 2 0.0000
541 BLOOD GLUCOSE DECREASED 2 0.0000
542 DRUG INTOLERANCE 4 0.0000
543 MYALGIA 7 0.0000
544 AGITATION 3 0.0000
545 INJECTION SITE URTICARIA 1 0.0000
546 PNEUMONIA ASPIRATION 1 0.0000
547 HOT FLUSH 3 0.0000
548 PRODUCT COMPLAINT 1 0.0000
549 HAEMATEMESIS 1 0.0000
550 HAEMOGLOBIN DECREASED 4 0.0000
551 ILLNESS 4 0.0000
552 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
553 SKIN ULCER 1 0.0000
554 ANXIETY 11 0.0000
555 PARAESTHESIA 6 0.0000
556 PANCREATITIS 2 0.0000
557 DEPRESSED MOOD 2 0.0000
558 CHEST PAIN 7 0.0000
559 DIARRHOEA 24 0.0000
560 JAUNDICE 1 0.0000
561 PAIN OF SKIN 1 0.0000
562 PALLOR 1 0.0000
563 PNEUMONITIS 1 0.0000
564 INFLUENZA LIKE ILLNESS 3 0.0000
565 PROCEDURAL PAIN 1 0.0000
566 DRUG ABUSE 3 0.0000
567 ALOPECIA 7 0.0000
568 DYSPNOEA 20 0.0000
569 PAIN IN JAW 1 0.0000
570 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
571 INFECTION 5 0.0000
572 ABDOMINAL PAIN 8 0.0000
573 LIVER FUNCTION TEST ABNORMAL 1 0.0000
574 PNEUMONIA 11 0.0000
575 LABORATORY TEST ABNORMAL 1 0.0000
576 RENAL INJURY 1 0.0000
577 CATARACT 2 0.0000
578 HYPOAESTHESIA 5 0.0000
579 IRRITABILITY 2 0.0000
580 BLOOD POTASSIUM DECREASED 1 0.0000
581 THERAPEUTIC RESPONSE DECREASED 2 0.0000
582 OEDEMA PERIPHERAL 4 0.0000
583 FEELING HOT 2 0.0000
584 NERVOUS SYSTEM DISORDER 1 0.0000
585 DRUG-INDUCED LIVER INJURY 1 0.0000
586 CYSTITIS 1 0.0000
587 PRURITUS 12 0.0000
588 HYPERHIDROSIS 4 0.0000
589 BLOOD CREATININE INCREASED 2 0.0000
590 PRODUCT DOSE OMISSION ISSUE 9 0.0000
591 STAPHYLOCOCCAL INFECTION 1 0.0000
592 BLOOD PRESSURE DECREASED 2 0.0000
593 EXPIRED PRODUCT ADMINISTERED 1 0.0000
594 DIZZINESS 15 0.0000
595 DEHYDRATION 4 0.0000
596 SKIN DISORDER 1 0.0000
597 URINARY RETENTION 1 0.0000
598 NEOPLASM MALIGNANT 2 0.0000
599 URTICARIA 5 0.0000
600 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
601 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
602 URINARY TRACT INFECTION 5 0.0000
603 FEELING ABNORMAL 7 0.0000
604 DEVICE USE ERROR 1 0.0000
605 COUGH 8 0.0000
606 PLATELET COUNT DECREASED 3 0.0000
607 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
608 THERAPY INTERRUPTED 2 0.0000
609 SKIN BURNING SENSATION 2 0.0000
610 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
611 PANIC ATTACK 1 0.0000
612 BRONCHITIS 2 0.0000
613 THROMBOCYTOPENIA 3 0.0000
614 ASTHENIA 10 0.0000
615 INTESTINAL OBSTRUCTION 1 0.0000
616 BLOOD PRESSURE INCREASED 4 0.0000
617 PLASMA CELL MYELOMA 1 0.0000
618 MALAISE 11 0.0000
619 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
620 EMOTIONAL DISTRESS 3 0.0000
621 DYSKINESIA 1 0.0000
622 NEUTROPHIL COUNT DECREASED 1 0.0000
623 ERYTHEMA 5 0.0000
624 SKIN EXFOLIATION 2 0.0000
625 HYPOACUSIS 1 0.0000
626 DEVICE LEAKAGE 1 0.0000
627 SEPTIC SHOCK 1 0.0000
628 MYOCARDIAL INFARCTION 4 0.0000
629 RENAL FAILURE 3 0.0000
630 PULMONARY OEDEMA 1 0.0000
631 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
632 PRODUCT QUALITY ISSUE 3 0.0000
633 INCORRECT DOSE ADMINISTERED 5 0.0000
634 SKIN IRRITATION 1 0.0000
635 OROPHARYNGEAL PAIN 2 0.0000
636 BACK PAIN 5 0.0000
637 CARDIAC DISORDER 2 0.0000
638 BLOOD GLUCOSE INCREASED 4 0.0000
639 ARRHYTHMIA 1 0.0000
640 RENAL CANCER 1 0.0000
641 NAUSEA 16 0.0000
642 SYNCOPE 2 0.0000
643 AGGRESSION 1 0.0000
644 FLUSHING 2 0.0000
645 HOSPITALISATION 3 0.0000
646 THERAPY CESSATION 1 0.0000
647 INFLAMMATION 1 0.0000
648 VOMITING 9 0.0000
649 NERVOUSNESS 1 0.0000
650 HAEMORRHAGE 2 0.0000
651 MUSCULOSKELETAL PAIN 1 0.0000
652 TREMOR 3 0.0000
653 NECK PAIN 1 0.0000
654 HERPES ZOSTER 1 0.0000
655 SURGERY 1 0.0000
656 DISEASE PROGRESSION 2 0.0000
657 SUICIDE ATTEMPT 1 0.0000
658 INJECTION SITE ERYTHEMA 2 0.0000
659 PRODUCT USE ISSUE 3 0.0000
660 PRODUCT DOSE OMISSION 1 0.0000
661 FEBRILE NEUTROPENIA 1 0.0000
662 FALL 5 0.0000
663 INSOMNIA 4 0.0000
664 DRY SKIN 2 0.0000
665 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
666 INJECTION SITE REACTION 1 0.0000
667 SLEEP DISORDER 1 0.0000
668 RESPIRATORY FAILURE 1 0.0000
669 UNEVALUABLE EVENT 1 0.0000
670 CHRONIC KIDNEY DISEASE 1 0.0000
671 INJECTION SITE SWELLING 1 0.0000
672 INJECTION SITE PAIN 4 0.0000
673 CARDIAC FAILURE CONGESTIVE 1 0.0000
674 THROMBOSIS 1 0.0000
675 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
676 CARDIAC ARREST 1 0.0000
677 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
678 PRODUCT STORAGE ERROR 1 0.0000
679 TACHYCARDIA 1 0.0000
680 SUICIDAL IDEATION 1 0.0000
681 ADVERSE EVENT 1 0.0000
682 CHEST DISCOMFORT 1 0.0000
683 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
684 INFLUENZA 1 0.0000
685 SEPSIS 1 0.0000
686 SEIZURE 1 0.0000
687 CHILLS 1 0.0000
688 DEATH 7 0.0000
689 PSORIASIS 1 0.0000
690 MEMORY IMPAIRMENT 1 0.0000
691 ACUTE KIDNEY INJURY 1 0.0000
692 ANAEMIA 1 0.0000
693 GAIT DISTURBANCE 1 0.0000